Cook Medical Group and Boston Scientific Corp. (NYSE:BSX) both got their start with catheter-based devices, but the medical device giants’ similarities don’t stop there. As Boston Scientific founder John Abele told MassDevice last month, his firm got its start in an unlikely place: the basement of a Catholic Church in Belmont, Mass.
Cook Medical
Cook recalls tracheostomy equipment
Cook Medical initiated a voluntary recall of its percutaneous tracheostomy devices that contain a Covidien (NYSE:COV) 6PERC or 8PERC Shiley tube.
According to the Food & Drug Administration, the Bloomington, Ind.-based medical product manufacturer’s recall comprises 17 lots of the ‘Ciaglia Blue Rhino’ and ‘Ciaglia Blue Dolphin’ introducer sets and trays.
MedGadget’s MedTech Monday: FDA approves the world’s most powerful CRT-D
FDA approves the world’s most powerful CRT-D: The Food & Drug Administration cleared Milan, Italy-based Sorin Group’s next-generation cardiac resynchronization therapy defibrillator, the Paradym CRT Model 8750. It’s the world’s most powerful CRT-D, according to the company, packing a 37-Joule punch. The company said it’s already been implanted in a first patient.
Boston Scientific begins biliary stent trial
Boston Scientific Corp. (NYSE:BSX) enrolled the first patient in a clinical trial of its WallFlex biliary stent for the treatment of benign bile duct strictures.
The Natick, Mass.-based medical device colossus said it plans to enroll 187 patients at 11 centers worldwide over the next 18 months for the trial, which will evaluate the removal of the stents from patients with benign bile duct strictures and the effectiveness of temporary stenting for long-term, benign biliary stricture resolution.